Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Cureus | Erythema Dyschromicum Perstans After Adalimumab Treatment
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
JCM | Free Full-Text | The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis | SpringerLink
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
Treatment of Recalcitrant Generalized Granuloma Annulare With Adalimumab - JDDonline - Journal of Drugs in Dermatology
Protect at all costs: How the maker of the world's bestselling drug keeps prices sky-high | Fortune
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy | HTML | Acta Dermato-Venereologica
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports
Dermatologic Therapy: Vol 33, No 3
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
Phototherapy remains a valuable psoriasis treatment
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent mali
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis | Nature Communications
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial - The Lancet Rheumatology
Clinical findings of the patient. (A) Erythematous scaly papules and... | Download Scientific Diagram
